A socially oriented non-financial development institution and a major organizer of international conventions, congress, exhibitions, business, social and sporting, public, and cultural events.

The Roscongress Foundation – a socially oriented non-financial development institution and a major organizer of international conventions, congress, exhibitions, business, social and sporting, public, and cultural events.

The Foundation was established in 2007 with the aim of facilitating the development of Russia’s economic potential, promoting its national interests, and strengthening the country’s image. One of the roles of the Foundation is to comprehensively evaluate, analyse, and cover issues on the Russian and global economic agendas. It also offers administrative services, provides promotional support for business projects and attracting investment, and helps foster social entrepreneurship and charitable initiatives.

Each year, the Foundation’s events draw participants from 208 countries and territories, with more than 15,000 media representatives working on-site at Roscongress’ various venues. The Foundation benefits from analytical and professional expertise provided by 5000 people working in Russia and abroad. In addition, it works in close cooperation with 126 economic partners; industrialists’ and entrepreneurs’ unions; and financial, trade, and business associations from 69 countries worldwide.

RC personal account
Восстановление пароля
Введите адрес электронной почты или телефон, указанные при регистрации. Вам будет отправлена инструкция по восстановлению пароля.
Некорректный формат электронной почты или телефона
Dmitry  Khalilov

Dmitry Khalilov

Partner, Head of the Group for the Provision of Services to Enterprises of the Consumer Goods Sector, CIS, EY
Quotes
08.06.2019
SPIEF 2019
Priority Strategies in the Supply of Drugs
If research on a drug is followed in a sufficiently thought-through way, then it will be possible to rework the budget in time to use it in the drug supply system. Identifying these drugs at an early stage and then using them in the system can lead to savings of up to 5%
26.05.2018
SPIEF 2018
Life Sciences in 2030: A New Era for Biotechnology
There is no stable regulatory environment in Russia. Still, frequently changing legislation does not keep pace with the development of the market. For example, legislation on biocell technology was adopted only in 2017–18
26.05.2018
SPIEF 2018
Life Sciences in 2030: A New Era for Biotechnology
We need certain state-set game rules that will be fixed at least in the medium term. The research takes a rather long period and the state should consistently and purposefully support the companies that will invest in investments
26.05.2018
SPIEF 2018
Providing Medications to the Russian Population
The objectives set by the President to the Government contain some rather ambitious requests – to increase life expectancy to 78, and to 80 by 2030. We must ensure the provision of medicine to a certain level in order to meet these objectives